What is the mid-term cure rate for testicular cancer

At present, the treatment effect of testicular cancer is very good. The cure rate of testicular cancer in the early stage is very high. So what is the cure rate of testicular cancer in the middle stage? In fact, the cure rate of testicular cancer is related to the patient himself. In addition, it is also related to the selected treatment plan. What is the cure rate of testicular cancer in the middle and late stages?

As DDP combined with chemotherapy becomes more mature, the survival rate of patients with disseminated testicular germ cell cancer continues to improve. The 3-year cancer-free overall survival rate has exceeded 80%, and the cancer-free survival rate of patients with mild and moderate dissemination can reach 99%, but the survival rate of widely disseminated cases is still less than 50%. Patients with mild and moderate dissemination of testicular cancer have a good prognosis. The current research focus is on how to reduce the toxicity of chemotherapy. The commonly used methods are to change 4 courses of chemotherapy to 3 courses or replace VLB with VP16, retain or cancel BLM, that is, replace the standard VPB regimen with PVP16 or PVP16B regimen, or replace DDP with carbon platinum (JM-8). The research direction of rescue chemotherapy for widely disseminated testicular cancer is mainly to find new combination drugs for DDP (such as ifosfamide), new chemotherapy regimens and high-dose DDP combined chemotherapy.

Testicular seminoma is sensitive to a variety of anti-tumor drugs. my country's first N-formyl sarcolytic agent is used to treat testicular seminoma. 150-200 mg is taken every night before bedtime, and 6-8 g is a course of treatment. The total effective rate is 91%, of which 2/3 are completely relieved. Recently, PVB or VAB-6 combined chemotherapy is mainly used, and the cure rate of stage III cases has reached 90%.

Testicular cancer occurs in testicular tissue and has a complex pathological origin. It is relatively rare clinically, accounting for about 1 percent of all male malignant tumors. The patient population is mainly young men in their peak reproductive years. Therefore, it has a relatively large impact on society, but the cure rate of testicular cancer is very high.